Design and application of antisense oligonucleotides in cell culture,in vivo, and as therapeutic agents
- 1 October 1994
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 14 (5) , 557-568
- https://doi.org/10.1007/bf02088837
Abstract
1. Synthetic oligonucleotides can inhibit the expression of a gene in a sequence specific manner on the transcriptional and translational level. These molecules are usually referred to as antisense oligonucleotides. 2. Antisense mediated inhibition of gene expression is a valuable tool to analyze the function of a genein vivo and can also be used for therapeutic gene suppression. 3. A number of factors such as the mode of action, specificity, chemistry, and pharmacology must be carefully considered for the design and successful application of antisense oligonucleotides. 4. Assay systems and controls must be chosen as to assure that the observed biological effects of antisense oligonucleotides do in fact reflect the result of a specific gene inhibition. 5. This article critically discusses these factors in view of the literature and our own experience with a wide range of cell types and animal models, targeting different genes. The emphasis is on the use of phosphorothioate oligodeoxynucleotides in cell cultures,in vivo, and as potential drugs.Keywords
This publication has 50 references indexed in Scilit:
- Block of c‐Fos and JunB Expression by Antisense Oligonucleotides Inhibits Light‐induced‐Phase Shifts of the Mammalian Circadian ClockEuropean Journal of Neuroscience, 1995
- The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptationsin vivoCellular and Molecular Neurobiology, 1994
- Sequence-specific impairment of learning by c-jun antisense oligonucleotidesNeuroReport, 1994
- A Unique c-myc-Targeted Triplex-Forming Oligonucleotide Inhibits the Growth of Ovarian and Cervical Carcinomas in VitroGynecologic Oncology, 1993
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Human therapeutics based on triple helix technologyTrends in Biotechnology, 1992
- Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Synthesis and Biophysical and Biological Evaluation of 2′-Modified Antisense OligonucleotidesNucleosides and Nucleotides, 1991
- Sugar modified oligonucleotides I. Carbo-oligodeoxynucleotides as potential antisense agentsBiochemical and Biophysical Research Communications, 1989
- Anti-messenger oligodeoxynucleotides: specific inhibition of rabbit β-globin synthesis in wheat germ extracts and Xenopus oocytesBiochimie, 1986